Calprotectin as a biomarker in rheumatoid arthritis: the potential predictive value of response to treatment

Alessia Caproli; Silvia Della Pina; Marika Vezzoli; Ilaria Cavazzana; Paolo Airò; Duilio Brugnoni; Franco Franceschini; Emirena Garrafa; Silvia Piantoni

doi:10.4155/bio-2023-0130

Calprotectin as a biomarker in rheumatoid arthritis: the potential predictive value of response to treatment

Bioanalysis. 2023 Sep;15(18):1111-1113. doi: 10.4155/bio-2023-0130. Epub 2023 Aug 16.

Authors

Alessia Caproli¹, Silvia Della Pina¹, Marika Vezzoli², Ilaria Cavazzana¹, Paolo Airò¹, Duilio Brugnoni³, Franco Franceschini¹, Emirena Garrafa^{2

3}, Silvia Piantoni¹

Affiliations

¹ Rheumatology & Clinical Immunology Unit, Department of Clinical & Experimental Sciences, Azienda Socio-Sanitaria Territoriale (ASST) Spedali Civili & University of Brescia, Brescia, 25100, Italy.
² Department of Molecular & Translational Medicine, University of Brescia, Brescia, 25100, Italy.
³ Department of Laboratory Diagnostics, Azienda Socio-Sanitaria Territoriale (ASST) Spedali Civili, Brescia, 25100, Italy.

PMID: 37584369
DOI: 10.4155/bio-2023-0130

No abstract available

Keywords: abatacept; biological drugs; biomarker; calprotectin; chemiluminescence; chronic arthritis; immunology; predictive value; rheumatoid arthritis; synovitis.

Publication types

Editorial

MeSH terms

Antirheumatic Agents* / therapeutic use
Arthritis, Rheumatoid* / diagnosis
Arthritis, Rheumatoid* / drug therapy
Biomarkers
Humans
Leukocyte L1 Antigen Complex / therapeutic use
Treatment Outcome

Substances

Leukocyte L1 Antigen Complex
Biomarkers
Antirheumatic Agents